Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update
In recent decades many potential serum biomarkers have been assessed in the diagnosis of ovarian cancer. Except cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), none of them have been applied to everyday clinical practice. Based on extensive scientific evidence, CA125 combined with H...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2022-01-01
|
| Series: | Menopause Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Current-clinical-application-of-serum-biomarkers-to-detect-and-monitor-ovarian-cancer-update,4,46144,1,1.html |